OptiNose Analyst Ratings
OptiNose Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/11/2023 | 141.94% | Piper Sandler | $4 → $3 | Maintains | Overweight |
11/14/2022 | 303.23% | BMO Capital | $6 → $5 | Maintains | Outperform |
10/21/2022 | 303.23% | Jefferies | → $5 | Assumes | → Buy |
03/05/2020 | 1593.55% | Cantor Fitzgerald | $27 → $21 | Reiterates | → Overweight |
12/18/2019 | 1916.13% | Cowen & Co. | → $25 | Initiates Coverage On | → Outperform |
08/13/2019 | 1835.48% | BMO Capital | $26 → $24 | Maintains | Outperform |
11/14/2018 | 2077.42% | Cantor Fitzgerald | $30 → $27 | Maintains | Overweight |
08/15/2018 | 2158.06% | BMO Capital | $30 → $28 | Maintains | Outperform |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
2023年08月11日 | 141.94% | 派珀·桑德勒 | $4→$3 | 維護 | 超重 |
2022年11月14日 | 303.23% | 蒙特利爾銀行資本 | $6→$5 | 維護 | 跑贏大盤 |
2022年10月21日 | 303.23% | 傑富瑞 | →$5 | 假設 | →購買 |
03/05/2020 | 1593.55% | 康託·菲茨傑拉德 | $27→$21 | 重申 | →超重 |
2019年12月18日 | 1916.13% | 考恩公司 | →$25 | 開始承保 | →跑贏大盤 |
2019年08月13日 | 1835.48% | 蒙特利爾銀行資本 | $26→$24 | 維護 | 跑贏大盤 |
2018年11月14日 | 2077.42% | 康託·菲茨傑拉德 | $30→$27 | 維護 | 超重 |
2018年08月15日 | 2158.06% | 蒙特利爾銀行資本 | $30→$28 | 維護 | 跑贏大盤 |
What is the target price for OptiNose (OPTN)?
OptiNose的目標價是多少?
The latest price target for OptiNose (NASDAQ: OPTN) was reported by Piper Sandler on August 11, 2023. The analyst firm set a price target for $3.00 expecting OPTN to rise to within 12 months (a possible 141.94% upside). 3 analyst firms have reported ratings in the last year.
派珀·桑德勒於2023年8月11日報道了OptiNose(納斯達克代碼:OPTN)的最新目標價。這家分析公司將目標價定為3美元,預計OPTN將在12個月內上漲至(可能上漲141.94%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for OptiNose (OPTN)?
分析師對OptiNose的最新評級是多少?
The latest analyst rating for OptiNose (NASDAQ: OPTN) was provided by Piper Sandler, and OptiNose maintained their overweight rating.
納斯達克分析師對OptiNose的最新評級由Piper Sandler提供,OptiNose維持其增持評級。
When is the next analyst rating going to be posted or updated for OptiNose (OPTN)?
OptiNose(OPTN)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OptiNose, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OptiNose was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與OptiNose的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。OptiNose的上一次評級是在2023年8月11日提交的,因此您應該預計下一次評級將在2024年8月11日左右提供。
Is the Analyst Rating OptiNose (OPTN) correct?
分析師評級OptiNose(OPTN)正確嗎?
While ratings are subjective and will change, the latest OptiNose (OPTN) rating was a maintained with a price target of $4.00 to $3.00. The current price OptiNose (OPTN) is trading at is $1.24, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的OptiNose(OPTN)評級維持不變,目標價在4.00美元至3.00美元之間。OptiNose目前的交易價格為1.24美元,超出了分析師的預測區間。